Key Events This Week
08 Jun: Stock opens at Rs.1.79, down 4.79% amid broad market weakness
09 Jun: MarketsMOJO upgrades rating to Sell on improved valuation and financial trends
10 Jun: Stock hits weekly low of Rs.1.63 following mixed earnings and valuation news
11 Jun: Price rebounds 4.29% to Rs.1.70 on increased volume
12 Jun: Week closes at Rs.1.75, down 0.31% on the day but volume surges
08 June 2026: Weak Start Amid Broader Market Decline
Evexia Lifecare opened the week at Rs.1.79, marking a 4.79% decline from the previous close. This drop coincided with a significant Sensex fall of 1.33%, which closed at 34,673.90. The stock’s volume of 14.6 million shares indicated active trading despite the negative sentiment. The broader market weakness set a cautious tone for the week ahead.
09 June 2026: Rating Upgrade Fails to Halt Price Slide
On 09 June, MarketsMOJO upgraded Evexia Lifecare’s rating from Strong Sell to Sell, citing improved valuation metrics and recent financial trends. The valuation grade shifted from expensive to fair, supported by a price-to-book value of 0.59 and a more balanced PEG ratio of 5.43. Despite this, the stock price declined further by 4.47% to Rs.1.71, underperforming the Sensex’s 0.88% gain that day. The upgrade reflected a nuanced improvement but did not immediately translate into positive price momentum.
10 June 2026: Mixed Financials and Valuation Concerns Weigh on Price
Evexia Lifecare’s stock reached a weekly low of Rs.1.63 on 10 June, down 4.68% amid mixed investor reactions to the company’s financial disclosures. Quarterly results showed a 52.2% surge in net sales to ₹36.79 crores and a PAT of ₹0.78 crore, signalling operational improvement. However, long-term fundamentals remained weak, with a five-year net sales CAGR of just 0.59% and a negligible ROCE of 0.10%. Elevated enterprise value multiples, such as EV to EBIT at 820.10, continued to raise concerns about profitability and capital efficiency. The Sensex also declined 0.61% to 34,766.59, reflecting broader market caution.
Fast mover alert! This Large Cap from Automobiles - Passeenger just qualified for our Momentum list with stellar technical indicators. Strike while the iron is hot!
- - Recent Momentum qualifier
- - Stellar technical indicators
- - Large Cap fast mover
11 June 2026: Price Recovery on Higher Volume
The stock rebounded 4.29% to close at Rs.1.70 on 11 June, supported by a surge in volume to nearly 19.8 million shares. This recovery occurred despite the Sensex declining 0.53% to 34,580.95, indicating some selective buying interest in Evexia Lifecare. The price movement suggested tentative investor confidence following the recent rating upgrade and quarterly results, though the stock remained well below its 52-week high of Rs.2.69.
12 June 2026: Week Ends with Modest Gains Amid Market Rally
On the final trading day of the week, Evexia Lifecare closed at Rs.1.75, up 2.94% on the day but still down 6.91% for the week. The Sensex rallied 2.20% to 35,342.50, outperforming the stock significantly. Volume surged to over 34 million shares, reflecting heightened trading activity. Despite the intraday gains, the stock’s weekly performance highlighted persistent challenges in sustaining upward momentum amid valuation and profitability concerns.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-06-08 | Rs.1.79 | -4.79% | 34,673.90 | -1.33% |
| 2026-06-09 | Rs.1.71 | -4.47% | 34,979.26 | +0.88% |
| 2026-06-10 | Rs.1.63 | -4.68% | 34,766.59 | -0.61% |
| 2026-06-11 | Rs.1.70 | +4.29% | 34,580.95 | -0.53% |
| 2026-06-12 | Rs.1.75 | +2.94% | 35,342.50 | +2.20% |
Key Takeaways
Valuation Adjustment: The upgrade from Strong Sell to Sell by MarketsMOJO was driven by a shift in valuation from expensive to fair, supported by a price-to-book value below 1 and a more balanced PEG ratio. However, extremely high EV multiples and a PE ratio of 155.08 continue to signal elevated risk.
Financial Performance: Quarterly results showed a strong 52.2% increase in net sales and a modest profit after tax of ₹0.78 crore, indicating operational improvement. Yet, long-term growth remains subdued with minimal returns on capital and equity, and high leverage reflected in a debt to EBITDA ratio exceeding 459 times.
Market Performance: The stock underperformed the Sensex throughout the week, falling 6.91% against a 0.57% gain in the benchmark. Despite a midweek rebound on increased volume, the overall trend was negative, reflecting investor caution amid mixed fundamentals.
Technical and Quality Factors: The stock’s wide 52-week trading range and micro-cap status contribute to volatility and liquidity concerns. The MarketsMOJO Mojo Score of 31.0 and Sell rating reflect these ongoing challenges despite recent improvements.
Considering Evexia Lifecare Ltd? Wait! SwitchER has found potentially better options in and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - + beyond scope
- - Top-rated alternatives ready
Conclusion
Evexia Lifecare Ltd’s week was characterised by a cautious recalibration of investor sentiment. The MarketsMOJO upgrade to a Sell rating reflected a modest improvement in valuation and recent financial trends, yet the stock’s price declined sharply, underperforming the broader market. Persistent challenges in profitability, capital efficiency, and leverage continue to weigh on the company’s outlook. While quarterly sales growth and profit gains offer some optimism, the stock remains a speculative proposition within the micro-cap edible oil sector. Investors should remain attentive to forthcoming financial disclosures and market developments to better gauge the sustainability of any recovery.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
